SCHEMBL28763389

SCHEMBL28763389

COc1cc2nn(C)nc2cc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
AXL P30530 1/20 0.40
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
HTR2A P28223 5/20 0.38
NPC1 O15118 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
SHMT2 P34897 1/20 0.38
HTR2C P28335 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14922469 0.85 NQO2 (0.46) MEN1KMT2AL3MBTL1USP2POLB
SCHEMBL31599989 0.79 LMNA (0.40) MEN1KMT2AL3MBTL1HTR2ANPC1
SCHEMBL31599834 0.76 S100B (0.50) MEN1KMT2AL3MBTL1NPC1CASP3
SCHEMBL22324000 0.75 PDGFRB (0.46) L3MBTL1AXLGRIN2DGRIN3BGRIN1
SCHEMBL23702268 0.74 MEN1 (0.43) MEN1KMT2AL3MBTL1AXLPOLB
SCHEMBL23643801 0.74 ALDH1A1 (0.42) AXLGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL28763374 0.74 MAPT (0.41) MEN1KMT2AL3MBTL1AXLGRIN2D
SCHEMBL16432372 0.74 AXL (0.42) AXLGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL26655062 0.74 FGFR1 (0.43) MEN1KMT2AL3MBTL1POLBALDH1A1
SCHEMBL26654804 0.74 MAPT (0.41) MEN1KMT2AL3MBTL1AXLGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025111547-A1 2,3-DIHYDROPYROLLOPYRIDINE CARBOXAMIDE COMPOUNDS AND METHODS OF USE THEREOF RGENTA THERAPEUTICS, INC. (US) 2025-05-30 WO disclosed
CN-110418790-B Imidazopyrrolone compounds as p53-MDM2 inhibitors 罗欣药业(上海)有限公司 2022-05-17 CN disclosed